Chicago—Any questions regarding the safety of tranexamic acid in patients undergoing cardiac surgery seem to have been put to rest with the ATACAS (Aspirin and Tranexamic Acid For Coronary Artery Surgery) trial.
“The concern has always been that since these drugs reduce bleeding, do they [also] increase thrombotic risk?” said ATACAS investigator Paul S. Myles, MD, a professor of anesthesia at Alfred Hospital and Monash University, in Melbourne, Australia. “There have